Federico Castiglione

Sequential Treatment with Exemestane and Non-Steroidal Aromatase Inhibitors in Advanced Breast Cancer

Gianfilippo Bertelli, Ornella Garrone, Marco Merlano et al. · Oncology · 2005 · 91 citations

Medicine, Oncology, Pharmacology +17

Time to Progression in Metastatic Breast Cancer Patients Treated With Epirubicin Is Not Improved by the Addition of Either Cisplatin or Lonidamine: Final Results of a Phase III Study With a Factorial Design

Alfredo Berruti, Raffaella Bitossi, G. Gorzegno et al. · Journal of Clinical Oncology · 2002 · 83 citations

Medicine, Oncology, Pharmacology +16

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network

Maria Pia Brizzi, Alfredo Berruti, Annamaria Ferrero et al. · BMC Cancer · 2009 · 62 citations · Full text

Medicine, Oncology, Pharmacology +16

Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients

Marco Tampellini, Alfredo Berruti, Raffaella Bitossi et al. · Breast Cancer Research and Treatment · 2006 · 39 citations

Medicine, Oncology, Pathology +15

Single-agent pegylated liposomal doxorubicin (Caelix®) in chemotherapy pretreated non-small cell lung cancer patients: a pilot trial

Gianmauro Numico, Federico Castiglione, Cristina Granetto et al. · Lung Cancer · 2002 · 30 citations

Pharmacy, Oncology, Pharmacology +12